Clinical Trials, Explained for Rural America.
46 million people live in rural America. Most have never been asked to take part in medical research. This page is here to change what you know about that.
There is a mental health emergency in rural America. Suicide rates run 64 to 68 percent higher than in the country's largest cities. Depression is more common. Psychiatrists are absent from 65 percent of rural counties. The treatments that exist were largely developed without rural patients in the room.
Rural Minds is partnering with Rising Tide Health to fix one piece of that. This page explains what clinical trials are, how they work, what protections you have, and how to find one that fits your life. No sales pitch. No fine print.
We start with the questions rural Americans actually ask.
Eight sections. Read straight through, or jump to what you need.
- Mental Health Is Physical Health1 min
- Why Clinical Trials Exist in the First Place1 min
- How Clinical Trials Actually Work3 min
- The Pill Penalty4 min
- Straight Answers to Honest QuestionsBrowse
- If You're Considering Participating2 min
- People Who Have Been ThereStories
- Where to Go NextDirectory
The whole page is about a fifteen-minute read. Most people skim and come back. That is fine.
Mental Health Is Physical Health
Before anything else, this needs to be said plainly.
Depression is a condition of the body. PTSD changes the brain in ways you can measure on a scan. Anxiety disorders have biological markers in the same way diabetes does. When a tractor is running rough, the operator does not get blamed. The right diagnostic gets pulled out, the right part gets ordered, the equipment goes back to work.
A mental health clinical trial is a tool. It tests whether a new treatment fixes the underlying problem better than the tools available now. The people who use that tool are people doing a job under high pressure who decided getting the diagnostic right was worth their time.
The rest of this page is written with that understanding in place.
Why Clinical Trials Exist in the First Place
For most of human history, medicine ran on guesswork. A doctor tried something. If the patient lived, the treatment was kept. If the patient died, it was sometimes discarded and sometimes kept anyway. Mercury was prescribed for syphilis well into the 20th century. Lobotomies won a Nobel Prize in 1949.
The problem was that one doctor's experience with a few patients was the standard of evidence. There was no reliable way to tell whether a treatment worked, whether the patient got better for some other reason, or whether the treatment was making things worse. That standard produced a lot of harm.
The clinical trial replaced guesswork with evidence. The idea is simple. If you want to know whether a treatment works, you have to give it to enough people, measure the results carefully, and compare them against what would have happened without it. You have to control for the things that fool you: the natural tendency of conditions to improve on their own, the placebo effect, the bias of researchers who want their treatment to succeed.
Every prescription medication available in the United States today went through this process. The blood pressure medication your spouse takes. The antidepressant your cousin started last year. The insulin your neighbor counts on. All of them passed through clinical trials before the FDA allowed them to be sold.
That is what clinical trials are for. They are the bridge between an idea that might help people and a treatment that does, with evidence strong enough to stake your health on.
How Clinical Trials Actually Work
Who runs them
Clinical trials in the United States are run by two main kinds of organizations.
Pharmaceutical and medical device companies. A company that has developed a new drug, vaccine, or device has to prove it works and is safe before the FDA will allow them to sell it. The company funds the trial and contracts with hospitals and clinics to enroll patients. Most large trials, especially the late-stage ones, are run this way.
Universities, academic medical centers, and government agencies. The National Institutes of Health funds thousands of trials every year, often for conditions where pharmaceutical companies have less commercial interest, or where the question is how existing treatments compare against each other.
In both cases, the same federal rules apply. Same informed consent. Same IRB oversight. Same FDA reporting. Who pays for a trial does not change the protections that govern it.
What gets tested
The same framework gets used to test more than new pills:
Drugs and biologics. New medications, new uses for existing ones, new dosing, new combinations.
Medical devices. Pacemakers, insulin pumps, hearing aids, surgical tools, diagnostic equipment.
Therapy and treatment approaches. A particular kind of talk therapy. A new way of structuring group treatment. A digital app for managing depression. These are tested in trials too.
Prevention strategies. Vaccines, lifestyle interventions, screening protocols. How to prevent a disease is as important a question as how to treat one.
The four phases
Most drug trials happen in four stages. The pattern is similar for devices and therapies.
Phase 1. A small group of people, usually 20 to 80, take the treatment for the first time. The goal is to see if it is safe at different doses.
Phase 2. A larger group, often a few hundred people, takes the treatment to see if it does what it is supposed to do.
Phase 3. Hundreds to thousands of people take the treatment, often compared against the current standard of care. This is where the case for FDA approval gets made.
Phase 4. After approval, doctors and researchers keep watching how the treatment works in everyday use.
What protects you in a trial
Informed consent. Before you sign anything, the research team has to explain in plain language what the trial is, what they will ask you to do, what the known risks are, and what is unknown. You can ask any question. You can take the consent form home and read it with your family. You can decide not to do it. And you can leave the trial at any point, for any reason, without affecting your regular medical care.
The IRB. Every clinical trial in the United States has to be reviewed and approved by an Institutional Review Board. The IRB is an independent group, including people who are not researchers, whose job is to make sure the trial is ethical and that participants are protected. If the IRB does not sign off, the trial does not happen.
The Pill Penalty
Here is a problem most rural Americans have never heard named.
When a mental health medication is tested for FDA approval, it gets tested mostly on the people who can drive to an academic medical center in a major city, fit study visits into a 9-to-5 schedule, and tolerate the side effects without losing their job or their housing. That is the population the dosing is calibrated for. That is the population the side effect profile is built from. That is who the package insert is written about.
Rural Americans get prescribed those same medications later, after FDA approval, with dosing instructions that were never validated on people doing physical work for fourteen hours a day, on people with different sleep cycles, on people with different exposures to pesticides and fuel and dust, on people who cannot easily get back to a pharmacy if the first dose causes a problem. A drug that works at one dose for a city office worker may need a different dose, different timing, or different monitoring for someone running a 200-acre dairy operation. Side effects that show up clearly in one population can be masked in another.
This is the Pill Penalty. Rural America pays it every time a mental health medication gets approved without rural participants in the trials.
The fix is straightforward. Rural Americans have to be part of the data that shapes the drug. Participation is how the medicine gets calibrated for the life you actually live.
Why mental health trials are harder to run
Cancer can be measured. A tumor shows up on a scan. A mass can be watched to see whether it shrinks. Mental health conditions work differently. There is no scan that shows depression, no blood test that confirms PTSD. Diagnosis is made by talking with the patient, and treatment progress is measured by how the patient is sleeping, functioning, and describing their mood. That makes mental health trials harder to run, harder to interpret, and slower to enroll. It is part of why the field has moved slowly for decades.
Why rural patients have stayed out
For most cancer patients, the social context around the diagnosis is supportive. Friends bring meals. Coworkers organize fundraisers. Employers accommodate treatment schedules.
People with mental health conditions live in a different world. The diagnosis can affect employment, gun ownership, custody arrangements, and social standing. Rural patients face this more sharply than most. The same stigma that keeps people from seeking mental health care keeps them out of mental health research, and the research base ends up built almost entirely on patients willing to identify themselves and walk into an academic medical center. That is a narrow slice of the people who actually live with these conditions, and it is a direct contributor to the Pill Penalty.
Why the next decade matters
Mental health treatment was stuck for a long time. The major classes of antidepressants in use today are mostly refinements of medications developed in the 1980s and 1990s. Treatment options that work well for severe depression, PTSD, and treatment-resistant conditions have been limited for decades.
That has started to change. There are trials underway for postpartum depression, first-episode psychosis, and the specific stress patterns affecting agricultural workers. New formulations of ketamine are reshaping treatment for severe depression. Digital tools are being tested alongside medication. Some of these will change mental health care over the next decade. The treatments that come out will be designed around the people who participated. If rural Americans are not in the data, the changes will be designed for someone else, and the Pill Penalty gets stamped onto a whole new generation of treatments.
The Next Generation of Care: Why Psychedelic Trials Matter Right Now
Psychedelic-assisted therapy is the most discussed development in mental health treatment today. Psilocybin, MDMA, and related compounds are in late-stage trials for PTSD, treatment-resistant depression, and substance use disorders. The early evidence is promising. The clinical results are not yet conclusive, the FDA has not approved any of these treatments, and the long-term picture will take years to establish.
What is true right now is that these trials are happening, that they represent the first real movement in mental health treatment in decades, and that they are recruiting. The people who participate today will shape who these treatments are approved for, how they are dosed, and which conditions they are made available for. Rural America has every reason to be in those trials, and almost no presence in them so far.
Roughly 6 percent of patients with mental health conditions participate in clinical trials. Fewer than 14 percent of those who do come from racial minority groups. The number of rural participants is harder to count, because most trials don't track rurality at all.
Straight Answers to Honest Questions
We get questions like these often from rural community members, mental health providers, and patient advocates. Click any question to read the answer.
No. That phrase comes from a real history that nobody should sugarcoat, and the rules around clinical trials today exist because of that history.
In a modern clinical trial, you are a participant with rights. You sign an informed consent form before anything happens, and you can read it as many times as you want before you sign. You can bring it to your own doctor. You can ask the research team to walk you through every line. If something is unclear, that is on them to fix.
You can leave the trial at any time. You do not have to give a reason. Your regular medical care will not be affected.
The research team is required to tell you about risks they know about and risks they suspect. They are required to update you if they learn something new during the trial that might change your decision to keep participating. That is the law, not a courtesy.
The opioid crisis was real. The damage it did to rural communities was real. Pharmaceutical companies have earned a lot of the skepticism they get, and we are not here to defend them.
The case for participating runs through the Pill Penalty. The medications that get approved reflect the people who showed up to test them. When rural Americans are absent from trials, the drugs that result are dosed around someone else's biology, designed for someone else's schedule, and tested for side effects in someone else's life. A medication that works at one dose for a city office worker may need a different dose, or different timing, for a farmer who has been on her feet for fourteen hours, who lives an hour from the nearest pharmacy, who has different exposures to pesticides and fuel, different sleep patterns, different access to follow-up care.
Participating in a trial does not require trust in pharma. Trust in the pharmaceutical company behind the trial is a separate question from trust in the protocol, the consent process, and the people running the study. Those things are designed to be evaluated separately. What participation does is put rural patients into the data that determines how the next generation of mental health medications gets built.
This is the question that comes up most often, and it deserves a careful answer.
Your participation is confidential. Federal law (HIPAA) protects your medical records. Research records have additional protections on top of that. The trial team cannot tell your employer, your neighbors, or anyone else that you are participating without your written permission.
Your gun rights. Participation in a clinical trial, by itself, is not a disqualifying condition for firearm ownership under federal law. What can affect firearm rights is an involuntary commitment or a court finding of mental incompetence, neither of which is something a clinical trial would cause or trigger. A trial is a voluntary medical research study. Nothing more.
Your insurance. The Genetic Information Nondiscrimination Act (GINA) and the Affordable Care Act prevent most forms of insurance discrimination based on health conditions or research participation. Life insurance and disability insurance have fewer protections, so if those matter to you, ask the trial team specifically how participation would appear in any records that might be shared with insurers.
Your community. Whether you tell anyone is your choice. The trial team will not.
If any specific concern matters to you, the research team is required to answer it before you consent. Write down your questions and bring them with you.
That used to be true. It is changing fast.
A lot of mental health and behavioral health trials now run with a mix of in-person and remote visits. Some have most visits done by video call from home. Some send a nurse to your house for blood draws or check-ins. Some use phone-based assessments. Some reimburse mileage, gas, lodging, and meals when in-person visits are required. A few cover childcare.
The reason this changed is partly pandemic, partly policy, and partly that researchers realized they were missing entire populations by only running trials in city hospitals. The infrastructure to include you exists now in a way it didn't five years ago.
Whether a specific trial works for your geography depends on the trial. Ask. The right question is "what does participation actually look like, week by week?" not "how far is the hospital from my house?"
Between 1932 and 1972, the U.S. Public Health Service ran a study in Tuskegee, Alabama, on 600 Black men. They had syphilis. They were not told they had syphilis. They were not treated, even after penicillin became the standard cure in the 1940s. The study lasted forty years. Many of the men died. Their wives were infected. Their children were born with congenital syphilis.
It was a moral catastrophe, and the rules that govern clinical trials in America today exist in large part because of it.
The 1974 National Research Act created the Institutional Review Board system. The 1979 Belmont Report established the three ethical principles that govern modern research: respect for persons, beneficence, and justice. The Common Rule, finalized in 1991 and strengthened since, requires informed consent in plain language, IRB oversight of every trial, and special protections for vulnerable populations.
None of that brings back the men who died. It means what happened to them cannot legally happen again. Researchers who violate informed consent face criminal penalties. Institutions that allow it lose their federal funding. The system is built on the assumption that participants need protection, and that those protections have to be enforced from outside the research team.
If you carry that history with you, you carry the right history. The question is whether the system in front of you today has changed enough to be worth your trust, and that is a decision only you can make.
Three things to know.
First, your identifying information (name, address, social security number) is kept separate from the medical data the researchers analyze. The research team works with coded data, not your name.
Second, data from federally funded trials gets reported to a public registry (clinicaltrials.gov) so the results are available to everyone, not just the company that ran the trial. This is meant to prevent companies from burying results that don't go their way.
Third, you have the right to ask what data the trial collects, where it is stored, who has access to it, and whether it will be used in any other research after the trial ends. Get the answer in writing before you sign.
Most trials offer some form of compensation. The most common forms are reimbursement for travel, parking, gas, lodging, and meals; a flat fee per study visit, often $25 to $150, depending on how long the visit is and what it involves; and coverage of medical costs related to the trial itself.
The compensation exists to cover what participation costs you and to acknowledge your time. It is not a paycheck. IRBs review compensation amounts to make sure they are not so high that they pressure people into joining a trial they wouldn't otherwise agree to.
If a trial offers compensation that feels out of proportion to what is being asked of you, that is worth asking about. Reasonable compensation for your time is standard. A figure that feels like a windfall might be a sign that the trial carries more risk than you have been told.
If You're Considering Participating
Two places to start.
Talk to your doctor or your nurse practitioner.
They can tell you if a trial is being run at their clinic, or if any local research network is recruiting in your area. If they don't know, that is information too. Many rural providers haven't been trained on the trial landscape, which is part of the problem this page is meant to address.
Use the Rising Tide app.
Most mental health and neurological trials never reach rural communities through the regular channels. They get listed in academic registries, recruited through urban clinics, and run by sites that assume patients live within a short drive. The Rising Tide app was built to close that gap. It surfaces trials you might qualify for, prioritizes the ones that can be done remotely or with minimal travel, and brings the research to your porch instead of asking you to find your way to it. The app is free. You enter your information, see what matches, and decide whether to follow up. Rural Minds and Rising Tide chose to work together because the app was already finding rural patients trials they didn't know existed.
Bring the research to your porch
The Rising Tide app filters for trials that can be done remotely, by phone, or with minimal travel. It is free. Enter your information, see what matches, decide whether to reach out. Nothing more.
Try the Rising Tide app →What to ask before you say yes
- What is this trial testing, and what is it trying to find out?
- What phase is it? How many people have taken this treatment before me?
- What will I have to do, week by week? How many visits? How long is each one?
- What are the known risks? What are the side effects you have seen so far?
- What happens if I want to stop?
- Will my regular doctor be in the loop?
- What does the trial cost me, and what gets reimbursed?
- Who reviews my safety during the trial?
- What happens to my data after the trial ends?
- Will I find out the results of the trial?
Red flags to watch for
A legitimate clinical trial:
- Is listed on clinicaltrials.gov
- Has an IRB approval letter the team can show you
- Gives you informed consent documents to take home
- Does not pressure you to decide on the spot
- Does not promise a cure or guaranteed results
- Does not ask you for upfront payment to participate
If you see any of those problems, walk away and tell someone. Email Rural Minds. We will help.
People Who Have Been There
If you have been part of a clinical trial and would be willing to share your experience, write to us at stories@ruralminds.org. Your story may help someone else decide.
Where to Go Next
-
In crisis? Call or text 988.The 988 Suicide and Crisis Lifeline. Free, confidential, available 24 hours a day.
-
Information and support for the full range of mental health conditions affecting rural America.
-
The federal registry of every clinical trial in the United States.
-
Free trial matching for mental health and neurological conditions.
-
Have a question we didn't answer?Email hello@ruralminds.org. We read every message.